Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged
pathogenic human coronavirus that belongs to the sarbecovirus lineage of the genus …

Abstract Coronavirus disease-2019 (COVID-19) is primarily a respiratory disease, however,
an increasing number of reports indicate that SARS-CoV-2 infection can also cause severe …

The ongoing global pandemic of Coronavirus disease 2019 (COVID-19) poses a serious
threat to human health, with patients reportedly suffering from thrombus, vascular injury and …

The COVID‐19 pandemic has caused an unprecedented health crisis and economic burden
worldwide. Its etiological agent SARS‐CoV‐2, a new virus in the coronavirus family, has …

The emergence of SARS-CoV-2 variants necessitates rational assessment of their impact on
the recognition and neutralization of the virus by the host cell. We present a comparative …

Human monoclonal antibodies (mAbs) that target the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) spike protein have been isolated from convalescent …

The pandemic of COVID-19 continues worldwide with many variants arising, especially
SARS-CoV-2 Delta (B. 1.617. 2) and Omicron (B. 1.1. 529) variants of concern (VOCs) …

CTL-mediated killing of virally infected or malignant cells is orchestrated at the immune
synapse (IS). We hypothesized that SARS-CoV-2 may target lytic IS assembly to escape …

The receptor-binding domain (RBD) is the essential part in the Spike-protein (S-protein) of
SARS-CoV-2 virus that directly binds to the human ACE2 receptor, making it a key target for …